Skip to content

Clinical trials

Diabetic Retinopathy trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Country / region: United Kingdom Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20101
20113
20122
20131
20144
20151
20162
20172
20183
20191
20203
20213
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting3
Terminated3
Active, not recruiting1
Withdrawn1
Unknown status1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Bayer3
Moorfields Eye Hospital NHS Foundation Trust3
Hywel Dda Health Board2
Novartis Pharmaceuticals2
Oxurion2
Quark Pharmaceuticals2
Queen's University, Belfast2
ThromboGenics2
BCN Peptides1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy36
Diabetes Mellitus11
Macular Edema5
Diabetes Complications4
Retinal Diseases4
Diabetic Nephropathies2
Cataract1
Choroidal Neovascularization1
Diabetes Mellitus, Type 11
Diabetes, Gestational1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.